hsa-miR-130a

ncRNA information

ncRNA name

hsa-miR-130a

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

SOX9

Downstream target

CTR1

Cancer information

Cancer name

Cervical Cancer

Cancer site

Cervix Uteri

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Up

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-130a mimics promoted the chemoresistance of the cervical cancer cell to DDP .

Tissue resource

cervical cancer tissues

human cervical cancer cell lines HeLa

human cervical cancer cell lines CaSki

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

the Second Xiangya Hospital of Central South University

American Type Culture Collection

Country

China

USA

Continent

Asia

North American